PATENT CLAIM ANALYSIS

Application Number: 16023477
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "282000"]

Abstract:
This present application disclosed a series of selective adenylyl cyclase 1 (AC1) inhibitors as a pain therapeutic. Those compounds may provide an effective method of treatment for chronic/inflammatory pain. Those compounds may also prevent opioid dependence and/or reduce opioid dependence. Both method and composition matters are within the scope of this invention.

Claim (Index 18):
A method for treating pain, opioid dependence, alcohol use disorder or autism comprising the step of administering to a mammal in need thereof a therapeutically effective amount of one or more compounds of  claim 1 , in combination with one or more other compounds by the same or different mode of action, and one or more carriers, diluents, or excipients, to a patient in need of relief from said disorder.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.28889
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14382645', '15772365', '15106363', '14377478', '10512986']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7152314093820953
- 35 USC 102 Novelty (BERT): 0.4979966282699191
- Combined Prediction Score: 0.6935079312708776
- Mean Citation Score: 212.417084
- Max Citation Score: 214.96663
- Similarity Product: 153.68900089216592

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test